PHARMACOGENETIC STUDY OF THE EFFECT OF POLYMORPHISMS IN THE TRAILR1/TRAIL SYSTEM ON THE RESPONSE TO TREATMENT WITH RITUXIMAB IN FOLLICULAR LYMPHOMA PATIENTS
PKP-014
VARIABILITY OF EXPOSURE PARAMETERS OF ADULTS TREATED WITH HIGH DOSES METHOTREXATE
PKP-012
MONITORING OF VANCOMYCIN IN 62 PATIENTS WITH CENTRAL NERVOUS SYSTEM INFECTIONS
PKP-011
PHARMACOTHERAPEUTICS MONITORING ANALYSIS OF VANCOMYCIN IN THE PHARMACEUTICAL SERVICE
PKP-010
HIGHER THAN RECOMMENDED DOSES OF COLISTIMETHATE SODIUM IN PATIENTS WITH MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS: A BENEFIT OR AN INCREASED RISK OF TOXICITY?
PKP-009
GENETIC POLYMORPHISMS OF EFECTIVENESS TO INTERFERON-B TREATMENT IN MULTIPLE SCLEROSIS
PKP-008
IMPROVING THE QUALITY OF CLINICAL DECISION MAKING BASED ON TOTAL PHENYTOIN SERUM LEVELS
PKP-007
APPROPRIATENESS OF SAMPLING TIMES FOR DRUG MONITORING IN THE EMERGENCY DEPARTMENT.
PKP-006
COMPARISON BETWEEN THE USE OF TOTAL/IDEAL/ADJUSTED BODY WEIGHT FOR EMPIRICAL VANCOMYCIN DOSING IN OBESE PATIENTS
PKP-005
Prognostic Impact of novel Gene Polymorphisms In Newly Diagnosed Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
PKP-004
CYP450 ISOENZYME-ASSOCIATED FOOD-DRUG INTERACTIONS ARE A NEGLECTED ISSUE IN MEDICINES INFORMATION
PKP-003
PHARMACOGENETICS IN ANTIPLATELET TREATMENT WITH CLOPIDOGREL IN VASCULAR PATHOLOGY
PKP-002
DECREASED LINEZOLID SERUM LEVELS IN CRITICALLY ILL PATIENTS: CLINICAL CASE STUDIES OF A DRUG-DRUG-INTERACTION BETWEEN LINEZOLID AND RIFAMPICIN
PKP-001
CURRENT VANCOMYCIN DOSING RECOMMENDATIONS FOR PAEDIATRIC PATIENTS: A PHARMACOKINETIC EVALUATION
PKP-008
ASSESSMENT OF THE EFFECTIVENESS OF MONITORING VANCOMYCIN IN PATIENTS UNDERGOING HAEMODIALYSIS
